Global Cardiac Monitoring Market - Focused Insights 2025-2030

MARKET INSIGHTS

The global cardiac monitoring market size was valued at USD 8.24 billion in 2024 and is expected to reach USD 13.24 billion by 2030, growing at a CAGR of 8.22% during the forecast period. The market is growing quickly because of new implantable, wearable, and portable heart monitors. This growth is mainly due to the increasing number of people with Atrial Fibrillation (AF) worldwide. The market is also expanding because digital technology is being used in heart monitoring, more people are experiencing heart diseases, and more consumers want to track their heart health.

MARKET DEFINITION

Cardiac monitoring is a way of watching and monitoring the electric activity of the heart through electrocardiography to ensure it is working normally. Cardiac monitoring required during several medical conditions can lead to abnormal heart rhythm or irregular heartbeats. It is a routine monitoring procedure for many patients’ care. Hospitals & clinics, specialty cardiac centers, diagnostics centers, and ambulatory care centers are commonly used cardiac monitoring systems.

MARKET TRENDS & DRIVERS

Development in Implantable Heart Monitors

Heart implant monitors are becoming a trendy solution to track heart rhythm for longer periods in the post-surgery period. Post-surgery cardiac monitoring activities are highly essential to track patients’ health and to avoid surgery follow-up, and re-operating. Based on that, research and manufacturers focus on the development and offering of next-generation implants that can measure volatile organic compounds, lactic acid, pH balance, and pressure and dissolve within the body. One such development is a soft implant monitor. Soft implants to assess post-surgery cardiac function could dissolve in the patient’s body and reduce the demand for follow-up surgery to remove it. This biocompatible, flexible device has components that sense changes in the level of volatile organic compounds and lactic acid as well as pressure and pH. Current cardiac monitors and therapeutic devices (pacemakers, defibrillators, and stents) which are widely available in the market, are made of rigid metal. Furthermore, these devices demand for extraction surgeries in case need of removal. These factors led to increasing demand for dissolvable cardiac implant monitors.

Growing Burden of Cardiovascular Diseases

Heart and blood vessel diseases, known as cardiovascular diseases (CVD), include conditions like stroke, coronary artery disease, and rheumatic heart disease. According to the World Heart Federation, about 0.5 billion people worldwide were affected by CVD in 2024, causing over 20 million deaths. Coronary heart disease, stroke, and high blood pressure-related conditions, which require heart monitoring, made up 10%, 9%, and 2% of all CVD cases each year. The rising number of CVD cases has increased the need for heart monitoring, leading to a high demand for cardiac monitors.

Rapid Acceptance OF Wearable Heart Monitoring Devices 

Recently, wearable heart monitors have gained significant importance in cardiovascular health monitoring due to several factors, including their non-invasiveness, continuous monitoring, and real-time data provisions. Cardiac monitoring, from data collection to processing, involves several repetitive and standard tasks. Where wearable heart monitors with the integration of advanced AI play a vital role. In addition, the expansion of the application of wearable technology for research studies and clinical trials fueling the market growth. Wearable heart monitors now have a wide range of potential clinical applications ranging from arrhythmia screening to remote management of severe chronic conditions such as coronary or peripheral artery diseases and heart failure.

GLOBAL CARDIAC MONITORING MARKET HIGHLIGHTS

• By Product: In 2024, the resting ECG segment dominates and holds the largest global cardiac monitoring market share of over 37%. A resting ECG records and monitors the heart’s electrical signals while the patient is calm and still. It is an important medical tool for detecting various heart conditions. Resting ECG is commonly used to identify irregular heartbeats (arrhythmias). Its use in heart disease care is growing because it helps detect conditions like angina, heart attacks, heart failure, and other heart abnormalities. Additionally, it can help identify heart problems early, recognize risk factors for heart disease, and provide a baseline ECG for future comparisons.
• By Mode: The ambulatory mode segment shows significant growth, with the fastest-growing CAGR of 9.79% during the forecast period. Ambulatory mode refers to the use of wearable and remote heart monitors outside of hospitals and clinics. These monitors are used in home care, remote care, and outpatient settings. Advances in technology, such as implantable cardiac monitors (ICMs), Holter monitors, and mobile cardiac telemetry (MCT), have made heart monitoring more portable. The small size and ease of use of these devices allow people to track their heart health even while working. Remote and ambulatory monitoring is becoming more common among doctors and patients for long-term heart monitoring and diagnosis. Improvements in hardware and software have led to cost-effective and practical devices that can send urgent alerts for medical emergencies while allowing vulnerable individuals to be monitored from home.
• By End-User: Based on the end-user, the hospital segment accounted for the largest global cardiac monitoring market share. Hospitals have emergency rooms, general wards, ICUs, surgery centres, and specialized departments where heart monitors are used for various purposes. From ECG tests to continuous heart monitoring, these systems are essential in hospital settings. Conditions like heart failure, blocked arteries, stroke, atrial fibrillation, and heart attacks lead to the most hospitalizations. The cardiac care unit (CCU) is a special ward for patients with serious heart problems. Patients recovering from heart surgeries or procedures are also monitored in the CCU. These units have advanced heart monitoring equipment and trained medical staff, helping improve heart care and treatment.

GEOGRAPHICAL ANALYSIS

North America dominates and holds the largest share and shows the highest growth in the global cardiac monitoring market, with the U.S. contributing to the highest revenue share as it is the largest economy in the region. North America spends the most on healthcare for heart diseases. The demand for heart monitoring is growing as more people use wearable and remote monitoring devices. With increasing awareness of heart health, more people are using health trackers, mobile apps, and smartwatches, making remote heart monitoring easier. In North America, the U.S. generates the most revenue because it has a large number of heart disease patients and high healthcare spending. Heart care services in the region are very advanced, helping more people adopt the latest heart monitoring technologies.

COMPETITIVE LANDSCAPE

The global cardiac monitoring market report consists of exclusive data on 60 vendors. Abbott, Boston Scientific Corporation, Medtronic, and Koninklijke Philips are some of the top companies in the global cardiac monitoring market. They provide high-quality and reliable heart monitoring products that meet customer needs and international standards. These companies are constantly improving their products and working to stay ahead in the market. They have a strong reputation and operate in many countries. To stay competitive, they launch new products, develop advanced technologies, and acquire other businesses. By using these strategies and expanding their capabilities, they have increased their market share and revenue.

RECENT VENDORS ACTIVITIES

• In 2024, Vivalink –a leading company in digital healthcare solution development and manufacturing launched a Turnkey ambulatory cardiac monitoring solution for Holter Monitoring and Mobile Cardiac Telemetry (MCT).
• In 2023, InfoBionic announced that it received FDA (510 K) approval for its advanced remote ECG monitoring device. This device produces Bluetooth diagnostic 6-lead sensors for patient-required cardiac monitoring.